GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 59 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,598,000 | +48.5% | 1,010,270 | +136.8% | 0.00% | +50.0% |
| Q3 2016 | $9,833,000 | +78.2% | 426,591 | +28.2% | 0.00% | +100.0% |
| Q2 2016 | $5,519,000 | +108.1% | 332,665 | +99.0% | 0.00% | 0.0% |
| Q1 2016 | $2,652,000 | -52.1% | 167,182 | -2.3% | 0.00% | 0.0% |
| Q4 2015 | $5,532,000 | -20.4% | 171,121 | +3.9% | 0.00% | -50.0% |
| Q3 2015 | $6,947,000 | – | 164,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |